Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. A complete primer on the medical uses of immunotherapy Cancer Immunotherapy: Principles and Practice offers thorough coverage of this emerging topic - from fundamentals and basic science to clinical application and toxicity management. The cutting-edge content, written by a world-renowned author team is presented in a concise, templated, easy-to-read format, and includes the latest guidelines for immunotherapy and toxicity management…mehr
Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. A complete primer on the medical uses of immunotherapy Cancer Immunotherapy: Principles and Practice offers thorough coverage of this emerging topic - from fundamentals and basic science to clinical application and toxicity management. The cutting-edge content, written by a world-renowned author team is presented in a concise, templated, easy-to-read format, and includes the latest guidelines for immunotherapy and toxicity managementHinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide
Inhaltsangabe
Current and Emerging Cancer Immunotherapies Brief Table of Contents Section I 1. Introduction to immunotherapy 2. Components of the immune system 3. Antibodies 4. B cells 5. T cells 6. NK cells 7. DC/macrophages 8. MDSC 9. Cytokines, chemokines, interferons 10. Vaccines 11. Oncolytic viruses 12. The immune system in cancer Section II Each chapter in this section will include: 1. A list of approved drugs 2. Info for each drug 3. Emerging Therapies: Pre-clinical and clinical data of new therapies, authors may include up to 3 figures in this section. 1. Bladder Cancer 2. Brain Cancer 3. Breast Cancer 4. Cervical Cancer 5. Colorectal Cancer 6. Gastric Cancer 7. Head and Neck Cancer 8. Leukemia- Acute Lymphoblastic 9. Leukemia- Acute Myeloid 10. Leukemia- Chronic Lymphocytic 11. Leukemia- Chronic Myeloid Leukemia 12. Lung Cancer 13. Lymphoma, Hodgkin 14. Lymphoma-Non-Hodgkin 15. Melanoma 16. Multiple Myeloma 17. Prostate Cancer 18. Renal Cell Carcinoma
Current and Emerging Cancer Immunotherapies Brief Table of Contents Section I 1. Introduction to immunotherapy 2. Components of the immune system 3. Antibodies 4. B cells 5. T cells 6. NK cells 7. DC/macrophages 8. MDSC 9. Cytokines, chemokines, interferons 10. Vaccines 11. Oncolytic viruses 12. The immune system in cancer Section II Each chapter in this section will include: 1. A list of approved drugs 2. Info for each drug 3. Emerging Therapies: Pre-clinical and clinical data of new therapies, authors may include up to 3 figures in this section. 1. Bladder Cancer 2. Brain Cancer 3. Breast Cancer 4. Cervical Cancer 5. Colorectal Cancer 6. Gastric Cancer 7. Head and Neck Cancer 8. Leukemia- Acute Lymphoblastic 9. Leukemia- Acute Myeloid 10. Leukemia- Chronic Lymphocytic 11. Leukemia- Chronic Myeloid Leukemia 12. Lung Cancer 13. Lymphoma, Hodgkin 14. Lymphoma-Non-Hodgkin 15. Melanoma 16. Multiple Myeloma 17. Prostate Cancer 18. Renal Cell Carcinoma
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826